Last reviewed · How we verify

NCT05410522

Electrostimulation Program for Lung Transplant Recipients in the ICU

Status unknown NA Last updated 8 June 2022
What this trial tests

NA trial testing EMS Program in Lung Transplantation in 58 participants. Status unknown.

Timeline
9 May 2022
Primary endpoint
21 December 2023
30 June 2024

Quick facts

Lead sponsorUniversidad Complutense de Madrid
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment58
Start date9 May 2022
Primary completion21 December 2023
Estimated completion30 June 2024
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad Complutense de Madrid — full company profile →

Who can join

18 and older, any sex, with Lung Transplantation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate rectus femoris muscle mass in lung transplant recipients and the effect of a training program during ICU admission based on the use of electrical muscle stimulation (EMS)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lung Transplantation

Currently open trials in the same condition.

Other Universidad Complutense de Madrid trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05410522.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing